Efficacy, safety, and tolerability of vortioxetine for the treatment of major depressive disorder in patients aged 55 years or older.
about
Efficacy, safety, and tolerability of vortioxetine for the treatment of major depressive disorder in patients aged 55 years or older.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy, safety, and tolerabi ...... tients aged 55 years or older.
@en
Efficacy, safety, and tolerabi ...... tients aged 55 years or older.
@nl
type
label
Efficacy, safety, and tolerabi ...... tients aged 55 years or older.
@en
Efficacy, safety, and tolerabi ...... tients aged 55 years or older.
@nl
prefLabel
Efficacy, safety, and tolerabi ...... tients aged 55 years or older.
@en
Efficacy, safety, and tolerabi ...... tients aged 55 years or older.
@nl
P2093
P2860
P1433
P1476
Efficacy, safety, and tolerabi ...... tients aged 55 years or older.
@en
P2093
Dapo Tomori
George G Nomikos
John Affinito
William Palo
P2860
P304
P356
10.1017/S1092852916000626
P577
2016-11-21T00:00:00Z